About Telegraph Hill Partners
Telegraph Hill Partners is a venture capital firm founded in 2001. It is primarily based out of San Francisco, United States. As of Jun 2026, Telegraph Hill Partners is an active investor, having invested in 52 companies, with 1 new investment in the last 12 months. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to HealthTech and High Tech. Most recently it participated in the $***** Seed round of etherFAX Overall, Telegraph Hill Partners portfolio has seen 3 IPOs and 30 acquisitions including key companies like Horizon Discovery, Carterra and Nivagen Pharmaceuticals. A lot of funds co-invest with Telegraph Hill Partners, with names like Piper Jaffray sharing a substantial percentage of its portfolio. Telegraph Hill Partners has team of 8 people including 5 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 5 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months
Telegraph Hill Partners' List of Top Investments
Telegraph Hill Partners has a portfolio of 52 companies. Their most notable investments are in Argonautms and PneumRx.Their portfolio spans across United States, United Kingdom, Belgium and 1 more locations. They have invested in Life Sciences, HealthTech, High Tech and 5 other sectors, across stages such as Series A, Series B and 5 more. Here is the list of top investments by Telegraph Hill Partners:
Developer of cell lines with genetic modification using AAV gene-editing platform. The company has cell line engineering, knockout cell lines, and reporter cell lines. It also provides services in T cell activation assay, lymphocyte reaction assay, T cell-mediated tumor cell lysis assay, ADCC, and CDC assays, gene-editing for immuno-oncology, CRISPR Screening, drug combination screening, in vitro assay, and in-vivo assay.
Key facts about Horizon Discovery
- Founded Year: 2007
- Location: Cambridge (United Kingdom)
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $46.3M
- Employee Count: 91 as on Aug 31, 2026
- Investors: ValueAct Capital, Draper Esprit and 14 Others
- Latest Funding Round: Post IPO, Sep 07, 2018, $*****
- Highlight: Acquired
2. Carterra
Carterra develops SPR based platforms to study enzyme kinetics. The company provides users with instruments and services that enable multiplexing on planar array surfaces. It has developed mAb characterization technology called LSA which is used to study epitope binding/mapping, kinetics, and quantitation. It also offers Continuous Flow Microspotter (CFM), which includes an array printing instrument and a microfluidic print head. Its products include spot CFM printhead, which uses a network of microchannels to deposit samples at one time in a block; and CFM instrument, which uses built-in sensors and pumps to control the flow within the CFM print head.
Key facts about Carterra
- Founded Year: 2004
- Location: Salt Lake City (United States)
- Stage: Acquired
- Total Funding till date: $47.1M
- Employee Count: 86 as on Aug 31, 2026
- Investors: Frazier VC, Ballast Point Ventures and 7 Others
- Latest Funding Round: Series G, Dec 07, 2023, $*****
- Highlight: Acquired
Key facts about Nivagen Pharmaceuticals
- Founded Year: 2009
- Location: Sacramento (United States)
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $31M
- Employee Count: 161 as on Aug 31, 2026
- Investors: BizCap, Telegraph Hill Partners and 2 Others
- Latest Funding Round: Series B, Aug 09, 2023, $*****
- Highlight: Acquired
4. RareCyte
Developer of technologies for the analysis of rare and single cells in the blood. The company's technologies enable convenient preparation and sophisticated multiparametric phenotypic analysis of rare cells including individual rare cell capture and retrieval for genomic analysis. Its technology platform has two integrated components AccuCyte (blood separation system) and CyteFinder (an instrument for cell imaging and analysis).
Key facts about RareCyte
- Founded Year: 2009
- Location: Seattle (United States)
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $114M
- Employee Count: 64 as on Aug 31, 2026
- Investors: Logos, GT Healthcare Capital Partners and 11 Others
- Latest Funding Round: Grant (prize money), May 20, 2025, $*****
- Highlight: Editors' Pick
5. Teknova
Provider of molecular biology research reagents and kits. It manufactures custom molecular biology media, buffers and reagents, pre-poured agar plates, dry culture media, liquid culture media, and media supplements to support molecular biology research. The products find applications in library screening, cloning, gene expression, DNA purification, transformation, mutagenesis, Southern, northern and western blotting, PCR, DNA sequencing, Phage display, immunology, etc.
Key facts about Teknova
- Founded Year: 1996
- Location: Hollister (United States)
- Annual Revenue: $10M - $50M as on Dec 31, 2025
- Stage: Public
- Employee Count: 188 as on Aug 31, 2026
- Investors: Cambrian Growth Partners, Telegraph Hill Partners and 2 Others
- Latest Funding Round: Post IPO, Sep 15, 2023, $*****
- Highlight: Public
Telegraph Hill Partners' Year-on-Year Investment Trends
Telegraph Hill Partners has invested in 55 companies over the last 24 years, with an average of 1 new investment annually in the last 10 years. As of Jun 2026, it has made 1 investment in this year. Its most recent first time investment was in etherFAX and most recent follow-on round was in Argonautms.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 0 | 1 |
2025 | 0 | 0 | 0 |
2024 | 1 | 1 | 2 |
2023 | 2 | 0 | 2 |
2022 | 2 | 0 | 2 |
2021 | 0 | 0 | 0 |
2020 | 1 | 1 | 2 |
2019 | 3 | 1 | 4 |
2018 | 1 | 1 | 2 |
2017 | 0 | 1 | 1 |
Telegraph Hill Partners' Investments by Stage
Telegraph Hill Partners has made 9 investments in Series A stage with an average round size of $12.9M, 9 investments in Series B stage with an average round size of $11.3M and 4 investments in Series C stage with an average round size of $28.9M.Stage of entry | No. of Investments |
|---|---|
Series A | 9 |
Series B | 9 |
Series C | 4 |
Seed | 3 |
PE | 2 |
Others | 2 |
Note: We have considered here, only first round of investments
Telegraph Hill Partners' Investments by Sector
Telegraph Hill Partners has a diverse portfolio, with companies operating in the Life Sciences, HealthTech, Healthcare, High Tech and Enterprise Applications. Notably, it has invested in 41 Enterprise (B2B) companies, 36 Tech companies, 14 Software companies and at least 10 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 22 |
HealthTech | 6 |
Healthcare | 5 |
High Tech | 5 |
Enterprise Applications | 4 |
Others | 1 |
Note: We have considered here, only first round of investments
Telegraph Hill Partners' Investments by Geography
Telegraph Hill Partners has made most investments in United States (27), followed by Canada where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 27 |
Canada | 1 |
United Kingdom | 1 |
Note: We have considered here, only first round of investments
Telegraph Hill Partners' recent investments
Telegraph Hill Partners has made 1 investments in 2026 so far - etherFAX.Here are the most recent investments by Telegraph Hill Partners:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jun 17, 2026 | United States | Seed | 4625 | - | |
Jun 27, 2024 | United States | Seed | 8860 | - | |
Mar 05, 2024 | United States | Series B | 8855 | ||
Aug 23, 2023 | United States | Series B | 1301 | - | |
Feb 15, 2023 | United States | Series A | 7394 |
IPOs and Publicly Listed companies in Telegraph Hill Partners' Portfolio
3 of Telegraph Hill Partners' portfolio companies have become public. Teknova got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jun 2021 at marketcap of $434M and Integra LifeSciences got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ).Here are Telegraph Hill Partners' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 25, 2021 | - | - | 4432 | |
Aug 16, 1995 | - | - | 5687 | |
Feb 03, 1995 | - | - | 4670 |
Acquired companies in Telegraph Hill Partners' Portfolio
30 companies from Telegraph Hill Partners' portfolio have been acquired. The most recent acquisition was Nivagen Pharmaceuticals in Jan 2026 by Pharmaceutical Associates for $*****.Here are Telegraph Hill Partners' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 06, 2026 | May 19, 2020 | Series B | 7834 | |
Jul 09, 2025 | Dec 05, 2019 | Series C | 1154 | |
Dec 13, 2024 | Apr 30, 2019 | Series A | 3772 | |
Jan 09, 2023 | - | - | 3471 | |
Aug 01, 2022 | Jan 17, 2018 | Series E | 6305 |
_1557135455897.png?devicePixelRatio=2&height=20&width=20){kind=logo}
_1557235014533.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Team profile of Telegraph Hill Partners
Telegraph Hill Partners has a team of 8 members including 5 Partners and 1 Venture Partner located in United States. Telegraph Hill Partners' team sits on the board of 1 company.Here is a list of all team members in Telegraph Hill Partners:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | San Diego | - | ||
Partner | - | - | ||
Partner | San Francisco | - | - | |
Partner | - | |||
Partner | United States | - | ||
Venture Partner | Guilford | - | - |
Co-investors of Telegraph Hill Partners
Over the past 24 years, 84 investors have co-invested in Telegraph Hill Partners's portfolio companies. This includes funds and angels.
- Invested before Telegraph Hill Partners: HHS, NIH SBIR/STTR and 21 others have invested in rounds before Telegraph Hill Partners. There are 3 companies where HHS has invested before Telegraph Hill Partners and 2 companies where NIH SBIR/STTR has invested before Telegraph Hill Partners.
- Top Co-investors of Telegraph Hill Partners: 24 investors entered a company along with Telegraph Hill Partners. These include investors like Piper Jaffray (1 company).
- Invested after Telegraph Hill Partners: A total of 37 investors have invested in Telegraph Hill Partners's portfolio after their investments. Top Investors include HHS (2 companies), PTV Healthcare Capital (2 companies) and Ballast Point Ventures (1 company).
Recent News related to Telegraph Hill Partners
•
EtherFax Secures Strategic Investment from Telegraph Hill Partners, Acquires Weave Cloud SolutionsPRWeb•Jun 16, 2026•etherFAX, Telegraph Hill Partners
•
Kytopen Secures Series B Funding to Boost Commercialization and Board ExpansionPR Newswire•Apr 07, 2026•Kytopen, Telegraph Hill Partners
•
Promptly Receives Strategic Minority Investment Led by Telegraph Hill Partners to Accelerate the Growth of its Patient Experience PlatformPRWeb•Jun 27, 2024•Promptly Health, Telegraph Hill Partners, Promptly Check-In
•
EditCo Bio and Telegraph Hill Partners Acquire Synthego's Engineered Cell Solutions Business to Enable Cellular ResearchPR Newswire•Mar 27, 2024•EditCo, Synthego, Telegraph Hill Partners
•
Argonaut Manufacturing Services Raises $45 MillionPulse 2.0•Mar 06, 2024•Argonautms, NewVale Capital, Telegraph Hill Partners, RBC Capital Markets and 1 other
•
Cell Microsystems raises $6.5 millionBusiness North Carolina•Aug 30, 2023•Cell Microsystems, Telegraph Hill Partners, Fluxion Biosciences
•
Metabolomics Research Services Firm Panome Bio Raises $6MGenomeWeb•Mar 15, 2023•Panome Bio, Telegraph Hill Partners, BioGenerator
•
Telegraph Hill Partners Raises $525M Fifth Fund for New Life Science and Healthcare InvestmentsPR Newswire•Jul 01, 2022•Telegraph Hill Partners
•
Mosaic Biosciences Secures Financing From Telegraph Hill Partners to Support Commercial Growth and Expand Drug Discovery Capabilities and ServicesBusiness Wire•Jun 14, 2022•Mosaic Biosciences, Telegraph Hill Partners
•
Cell Microsystems Raises $10M in Growth FundingGenomeWeb•Nov 15, 2021•Cell Microsystems, Telegraph Hill Partners
